Generation of three human induced pluripotent stem cell (hiPSC) lines from patients with Late-Onset Tay-Sachs disease (HEXA-related adult-onset GM2-gangliosidosis)
Open Access
- 9 August 2025
- journal article
- Published by Elsevier in Stem Cell Research
- Vol. 87, 103801
Abstract
No abstract availableKeywords
Funding Information
- Fondation pour la Recherche Médicale
This publication has 11 references indexed in Scilit:
- Natural History of Adult Patients with GM2 GangliosidosisAnnals of Neurology, 2020
- Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs diseaseOrphanet Journal of Rare Diseases, 2018
- Cerebral organoids derived from Sandhoff disease-induced pluripotent stem cells exhibit impaired neurodifferentiationJournal of Lipid Research, 2018
- Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs diseaseExperimental Neurology, 2018
- Gangliosides and Gangliosidoses: Principles of Molecular and Metabolic PathogenesisThe Journal of Neuroscience, 2013
- Late onset Tay–Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous systemBrain Research, 2004
- Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantationProceedings of the National Academy of Sciences, 2000
- Mouse models of Tay–Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolismNature Genetics, 1995
- Neuropathology of Late Onset GangliosidosesDevelopmental Neuroscience, 1991
- The Mutations in Ashkenazi Jews with Adult G M2 Gangliosidosis, the Adult Form of Tay-Sachs DiseaseScience, 1989